- Home
- BBOT vs EQBK Comparison
BBOT vs EQBK Comparison
Compare BBOT & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBOT | EQBK |
|---|---|---|
| Founded | 2016 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 870.8M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BBOT | EQBK |
|---|---|---|
| Price | $8.70 | $43.99 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | $24.00 | ★ $50.50 |
| AVG Volume (30 Days) | ★ 184.8K | 96.9K |
| Earning Date | 03-05-2026 | 04-14-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.23 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.58 |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ N/A | $35.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.67 | $34.11 |
| 52 Week High | $14.87 | $50.07 |
Technical Indicators
Market Signals| Indicator | BBOT | EQBK |
|---|---|---|
| Relative Strength Index (RSI) | 35.25 | 45.21 |
| Support Level | N/A | $42.84 |
| Resistance Level | $12.36 | $44.50 |
| Average True Range (ATR) | 0.55 | 1.10 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 3.28 | 51.49 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.